— Cutting-edge prostate cancer projects range from AI-powered diagnosis and risk prediction to targeted therapies that overcome treatment resistance — The Prostate Cancer Foundation (PCF) today ...

Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific and overall survival significantly. Chemoradiation did not enhance relapse ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how advanced artificial intelligence and population health analytics can identify ...

Atezolizumab, combined with chemotherapy, did not improve survival in high-risk triple-negative breast cancer and had higher severe adverse events. A Swedish study found 30% of breast cancers were ...

A single-drug approach for newly diagnosed multiple myeloma may simplify treatment while maintaining efficacy, improving patient quality of life. Suleika Jaouad's leukemia experience highlights the ...